Share This

Related Topics News -

     
 Title only   |   Print 
     
《業績》復星醫藥首季淨利潤6.1億人民幣 倒退38.2%

2024-04-30T  
復星醫藥子公司治療抗結核新藥註冊申請獲批

2024-04-25T  
復星醫藥控股子公司藥物註冊申請獲國家藥監局受理

2024-04-17T  
復星醫藥子公司藥物獲批開展臨床試驗

2024-04-17T  
歐盟傳最早4月對中國醫療器械採購啟動調查 或影響中資投標

2024-04-15T  
國家醫保局:第九批藥品集採每年為患者節省182億元人幣

2024-04-09T  
復星醫藥子公司兩款藥物註冊申請獲國家藥監局受理

2024-04-08T  
《全日總結》恆指跌1點 匯控友邦造好 醫藥股普遍受壓

2024-04-05T  
《半日總結》恆指跌118點 匯控友邦逆漲 中海油服挫18%

2024-04-05T  
復星醫藥與深圳引導基金成立合資基金

2024-04-03T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.